Product Description
Temirazer is a far-reaching powerful antiretroviral sedate for the treatment of HIV-1 and HIV-2 contaminations in patients more than 18 years old. Can be taken correspondingly with other comparative medications. Temirazer is doled out to a gathering of non-nucleoside inhibitors with turnaround transcriptase, otherwise called a protease inhibitor. The medication contains two fundamental dynamic fixings - tenofovir and emtricitabine, because of which the medication has a viable impact in the battle against HIV contaminations, keeping the infection from spreading in the host's body.